Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed London Stock Exchange - 06/18 11:35:19 am
1676 GBp   -0.59%
5h ago GLAXOSMITHKLINE PLC: Transaction in Own Shares
9h ago GLAXOSMITHKLINE PLC: GSK receives offer for its thrombosis brands and rela..
9h ago GSK negotiating $1 billion sale of thrombosis drugs to Aspen
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

GlaxoSmithKline And University Of Nottingham Establish Research Center

04/26/2012| 04:46am US/Eastern
Recommend:
0

Drug maker GlaxoSmithKline PLC (>> GlaxoSmithKline plc) and the University of Nottingham said Thursday that they formalized a collaboration to establish a new laboratory to accommodate the Centre of Excellence for sustainable chemistry and to construct an innovative carbon neutral sustainable chemistry laboratory.

MAIN FACTS:

-The Laboratory for Sustainable Chemistry is being supported by a GBP12 million grant from Glaxo.

-Shares at 0829 GMT, down 10 pence, or 0.71%, at 1,403.5 pence valuing the company at GBP71.28 million.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
Recommend :
0
Partner Area
React to this article
 
Latest news on GLAXOSMITHKLINE PLC
5h ago GLAXOSMITHKLINE PLC: Transaction in Own Shares
9h ago GLAXOSMITHKLINE PLC: GSK receives offer for its thrombosis brands and related m..
9h ago GSK negotiating $1 billion sale of thrombosis drugs to Aspen
9h ago Royalty drops hostile bid for Ireland's Elan
11h agoDJGlaxo Gets Offer For Thrombosis Brands, Related Manufacturing Site
11h agoDJGLAXOSMITHKLINE PLC: GSK receives offer for Thrombosis Brands
1d agoDJStudies Fail to Back Medtronic Drug Claims
1d ago GLAXOSMITHKLINE PLC: Transaction in Own Shares
1d agoDJLONDON MARKETS: Oil Firms Boost FTSE 100 After Upgrade
1d agoDJAmicus Therapeutics Delays Seeking OK For Fabry Drug, Shares Fall
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
GlaxoSmithKline plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.